By George W. Chapman Passed in March, the $1.9 trillion package afforded more relief to people living at poverty levels who are insured through
COVID-19: Experts Believe Virus is Here to Stay By George W. Chapman The FDA will expedite the review process for manufacturers developing updates and
By George W. Chapman A Democratic president will have minimal to no impact on any attempt to reign in drug prices if Republicans retain
By George W. Chapman The FDA has made clear it will not take potentially dangerous short cuts when granting emergency authorization to vaccine producers.
By George W. Chapman Elections are just around the corner and political ads, national and local, are rife with claims that their candidate is
By George W. Chapman The short answer is: don’t hold your breath. A recent article in the New York Times by Reed Abelson explained.
By George W. Chapman What tends to get lost in all the headline-grabbing news related to the pandemic (PPE shortages, morbidity, testing, lingering long
By George W. Chapman No one could have predicted that a pandemic would be the catalyst or “black swan” event for telehealth. Up until
By George W. Chapman In late April, the Centers for Medicare & Medicaid Services (CMS) issued radical changes to combat the COVID-19 pandemic. The
By George W. Chapman Various computer models have attempted to predict U.S. deaths from the coronavirus pandemic. The earliest estimates were upwards of one